News Maxor’s Response to the Coronavirus Mar 13, 2020 Clinical News, COVID-19, Maxor Pharmacy Management, Maxor Specialty, Maxor340B, MaxorPlus This memo details Maxor’s perspective on the current COVID-19 situation and contingency planning across Maxor’s various business lines, including PBM, retail/hospital pharmacy, and specialty pharmacy. READ MORE Related News MaxorPlus Market Trends Webinar – Watch Now Clinical News, Maxor, MaxorPlus Introducing the MaxorPlus Care Improvement Programs via Clinical Concierge Clinical News, Maxor, MaxorPlus Maxor Chief Pharmacy Officer, Michael Einodshofer, officially becomes Chairman of the Board during NASP 2020 Industry News, Maxor, Maxor Specialty, MaxorPlus, Press Releases See more news. Categories Clinical News COVID-19 Industry News Maxor Maxor Pharmacy Management Maxor Specialty Maxor340B MaxorPlus Press Releases
Introducing the MaxorPlus Care Improvement Programs via Clinical Concierge Clinical News, Maxor, MaxorPlus
Maxor Chief Pharmacy Officer, Michael Einodshofer, officially becomes Chairman of the Board during NASP 2020 Industry News, Maxor, Maxor Specialty, MaxorPlus, Press Releases
